Johnson & Johnson agreed to acquire mental-illness drug developer Intra-Cellular Therapies for about $15 billion.

The Brooklyn Nets knew they needed someone to step up when Mikal Bridges was traded to the New York Knicks over the summer. While Cam Thomas was a likely candid ...

Tom Brady is learning on the fly. Brady is part owner of the Las Vegas Raiders, which is a lovely step for his post-playing career, but also makes his other job ...

Johnson & Johnson has entered an agreement to acquire all outstanding shares of Intra-Cellular Therapies, in a ...

Johnson & Johnson will spend more than $14 billion to move deeper into treating central nervous system disorders by ...

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to ...

Briana Johnson who lost her family home in the Eaton fire recounted to Newsweek about the lack of communication around evacuating.

A reported favorite in the Raiders GM search has surfaced and it's questionable whether it benefits them in a quest to beat ...

During the early December press conference announcing Matt Eberflu’s ouster, Chicago Bears CEO Kevin Warren made comments ...

The Bears are in danger of losing another. Detroit Lions offensive coordinator Ben Johnson had a virtual interview with the Bears on Saturday. Chicago cannot interview Johnson in person until at least ...

The biopharma industry’s deal-a-palooza, better known as the J.P. Morgan Healthcare Conference, has kicked off in San ...

Intra-Cellular Therapies (ITCI) stock rose more than 35% premarket after Johnson & Johnson (JNJ) agreed to buy the biopharmaceutical company for $132 a share. Read more: ...